Patent ID: 8114856

Claim:
A compound having the following formula VI: or a prodrug or pharmaceutically acceptable salt thereof, wherein: Q1 is —NR 10 R 11 ; Q 2 is each Q 3 and Q 4 is —OR 7 ; Q 5 is —OR 8 ; each of R 1 , R 6 , R 7 and R 8 is, in each instance, H; each R 2 and R 10 is, independently, H, C 1 -C 12 alkyl or substituted C 1 -C 12 alkyl; R 11 is cyano, C 1 -C 12 alkyl, substituted C 1 -C 12 alkyl, C 2 -C 12 alkenyl, substituted C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, substituted C 2 -C 12 alkynyl or —(CH 2 ) n -(L 1 ) m -(CH 2 ) nn -E 1 ; L 1 is S, O or NJ 1 ; n is an integer from 1 to 8; m is 0 or 1; nn is 0 or an integer from 1 to 8; mm is 1 or 2; E 1 is H, hydroxyl, halogen, cyano, —NJ 1 J 2 , C 2 -C 12 alkenyl, substituted C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, substituted C 2 -C 12 alkynyl, C 5 -C 20 aryl, substituted C 5 -C 20 aryl, heteroaryl, substituted heteroaryl, a heterocyclic radical, a substituted heterocyclic radical or a substituted or unsubstituted mono or poly cyclic structure that is unsaturated, partially saturated or fully saturated and optionally includes one or more heteroatoms selected from O, N and S; each J 1 and J 2 is, independently, H, C 1 -C 12 alkyl, substituted C 1 -C 12 alkyl, C 2 -C 12 alkenyl, substituted C 2 -C 12 alkenyl, C 2 -C 12 alkynyl, substituted C 2 -C 12 alkynyl, C 5 -C 20 aryl, substituted C 5 -C 20 aryl, —C(═O)—X, a heterocyclic radical or a substituted heterocyclic radical; each X is, independently, H, C 1 -C 12 alkyl or substituted C 1 -C 12 alkyl; and Z 1 and Z 2 are each, independently, H or —OH.